Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient adalimumab (ATC code according to WHO: L04AB04) - 8923798

World Biggest Tenders Source

This tender with title Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient adalimumab (ATC code according to WHO: L04AB04) - 8923798 has been published on Bidding Source portal dated 14 Oct 2026 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient adalimumab (ATC code according to WHO: L04AB04) - 8923798

Tender Type :

Invitation for Bids

Reference No. :

8923798

Country :

Germany

Publish Date :

14 Oct 2026

Closing Date :

30 Jun 2028

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Agreement not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient rotigotine (ATC code according to WHO: N04BC09), excluding packs larger than 84 units - 8922278 Germany Agreement not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient tiotropium bromide (ATC code according to WHO: R03BB04) - 8922279 Germany Open House Biologics Discount Agreements 2026-29 Rituximab (finished medicinal products only) - 8925122 Germany Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient estradiol (ATC code: G03CA03). - 8923801 Germany Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient filgrastim (ATC code: L03AA02). - 8923802 Germany Agreement not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient Etanercept (ATC code according to WHO: L04AB01) - 8922277 Germany Open House Discount Agreements 2024-11 - 8476857 Germany Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient tafamidis (ATC code: N07XX08) in the strength of 20 mg. - 8474949 Germany Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient tiotropium bromide (ATC code: R03BB04) in the dosage form of inhalation solution. - 8474950 Germany Open House Contracts 2026-1 - 8476856 Germany

Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient adalimumab (ATC code according to WHO: L04AB04) - 8923798

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com